Biotech Company News Biotechnology High Dose of Pfizer’s Xeljanz Raises Red Flag in a Post-Marketing Study By Staff Reports 2 months ago Pfizer‘s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for
Biotech Company News Merck to Acquire Immune Design By Staff Reports 2 months ago Merck and Immune Design announced that the companies have entered into a definitive agreement under
Biotech Company News Gilead misses key goal in NASH liver disease trial By Staff Reports 2 months ago CHICAGO (Reuters) – Gilead Sciences Inc said on Monday that a late-stage study of a
Biotech Company News Biotechnology Diabetes New Sensor to Monitor Blood Sugar Through a Breath By Staff Reports 2 months ago It’s a breath of fresh air for people with diabetics. A simple puff into a
Biotech Company News cancer Clinical Trials Eureka Therapeutics Announces Us FDA Clearance of IND Application for Phase 1/2 Trial of Et140202 Artemis T-Cell Therapy, For The Treatment of Liver Cancer By Staff Reports 3 months ago Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, announced that
Biotech Company News Q BioMed Seeks Multi-billion Dollar Opportunity with New Glaucoma Treatment Candidate By Staff Reports 3 months ago Shares of Q BioMed Inc.(OTCMKTS: QBIO) rose sharply on heavy volume after the company announced
Biotech Company News Bristol-Myers Squibb to Acquire Celgene By Staff Reports 4 months ago Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal (Reuters) – Bristol-Myers Squibb Co
Biotech Company News IntraBio Receives Niemann-Pick disease European Orphan Drug Designation for IB1000 Series By Staff Reports 5 months ago IntraBio Inc., a late-stage biopharmaceutical company developing novel therapies for rare “orphan” and common neurodegenerative